Westbourne Investments Inc. Buys Shares of 31,985 GE HealthCare Technologies Inc. $GEHC

Key Points

• Westbourne Investments Inc. has acquired 31,985 shares of GE HealthCare Technologies Inc., valued at approximately $2.58 million, representing 1.6% of its total portfolio.
• Several analysts have upgraded the stock's rating, with a consensus rating of "Moderate Buy" and a target price of $88.40.
• GE HealthCare Technologies recently reported quarterly earnings surpassing expectations, with a revenue of $5 billion and a dividend yield of 0.2%.

Westbourne Investments Inc. bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 31,985 shares of the company's stock, valued at approximately $2,582,000. GE HealthCare Technologies comprises about 1.6% of Westbourne Investments Inc.'s holdings, making the stock its 12th biggest position.

Other large investors have also recently bought and sold shares of the company. N.E.W. Advisory Services LLC acquired a new stake in GE HealthCare Technologies during the 1st quarter valued at $25,000. Bogart Wealth LLC boosted its holdings in shares of GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after purchasing an additional 247 shares during the last quarter. Stonebridge Financial Group LLC boosted its holdings in shares of GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after purchasing an additional 222 shares during the last quarter. Ameriflex Group Inc. acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $31,000. Finally, Olde Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $35,000. Institutional investors and hedge funds own 82.06% of the company's stock.

Analyst Upgrades and Downgrades

GEHC has been the topic of several analyst reports. Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. Wall Street Zen upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Citigroup lifted their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a report on Thursday, July 31st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Finally, Morgan Stanley reduced their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $88.40.

GE HealthCare Technologies Trading Down 0.4%

NASDAQ:GEHC opened at $78.42 on Wednesday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The firm has a market capitalization of $35.80 billion, a PE ratio of 16.12, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The business's 50-day moving average is $74.42 and its two-hundred day moving average is $73.83.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period in the previous year, the company earned $1.00 earnings per share. The company's revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.